- Home
- TNGX vs LQDT Comparison
TNGX vs LQDT Comparison
Compare TNGX & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- LQDT
- Stock Information
- Founded
- TNGX 2014
- LQDT 1999
- Country
- TNGX United States
- LQDT United States
- Employees
- TNGX N/A
- LQDT 781
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- LQDT Catalog/Specialty Distribution
- Sector
- TNGX Health Care
- LQDT Consumer Discretionary
- Exchange
- TNGX Nasdaq
- LQDT Nasdaq
- Market Cap
- TNGX 723.2M
- LQDT 862.5M
- IPO Year
- TNGX N/A
- LQDT 2006
- Fundamental
- Price
- TNGX $7.35
- LQDT $28.05
- Analyst Decision
- TNGX Strong Buy
- LQDT Strong Buy
- Analyst Count
- TNGX 6
- LQDT 2
- Target Price
- TNGX $10.00
- LQDT $38.50
- AVG Volume (30 Days)
- TNGX 1.5M
- LQDT 204.7K
- Earning Date
- TNGX 11-05-2025
- LQDT 08-07-2025
- Dividend Yield
- TNGX N/A
- LQDT N/A
- EPS Growth
- TNGX N/A
- LQDT 33.77
- EPS
- TNGX N/A
- LQDT 0.83
- Revenue
- TNGX $24,296,000.00
- LQDT $465,508,000.00
- Revenue This Year
- TNGX $20.42
- LQDT $31.57
- Revenue Next Year
- TNGX N/A
- LQDT $2.58
- P/E Ratio
- TNGX N/A
- LQDT $33.26
- Revenue Growth
- TNGX N/A
- LQDT 38.40
- 52 Week Low
- TNGX $1.03
- LQDT $21.23
- 52 Week High
- TNGX $10.81
- LQDT $39.72
- Technical
- Relative Strength Index (RSI)
- TNGX 60.63
- LQDT 53.23
- Support Level
- TNGX $6.38
- LQDT N/A
- Resistance Level
- TNGX $6.90
- LQDT $27.44
- Average True Range (ATR)
- TNGX 0.44
- LQDT 0.55
- MACD
- TNGX 0.00
- LQDT -0.93
- Stochastic Oscillator
- TNGX 94.14
- LQDT 99.96
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.